Cervical Cancer

Surgical blood transfusions do not affect relapse, survival risk

Published in Cancer Weekly, November 19th, 2002

by Michael Greer, senior medical writer - Researchers in the United States have elucidated the effect of blood transfusions on the safety and efficacy of surgery to treat cervical cancer.

Nick M. Spirtos and colleagues at the Women's Cancer Center of Northern California in Palo Alto and other institutions in Buffalo, Miami, and Durham, North Carolina, evaluated the relapse and survival rates for patients who received perioperative blood transfusions.

The use of blood products during surgery had no significant effect on the risk of postoperative mortality or relapse risks, Spirtos and coauthors found.

The researchers examined data...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-11-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry